Reply to K. Quan et al, S.p. Collins et al, C.R. King et al, S. Arcangeli et Al, D.B. Fuller, and D. Vordermark.
Autor: | Yu JB; Yale University School of Medicine, New Haven, CT james.b.yu@yale.edu., Cramer LD; Yale University School of Medicine, New Haven, CT., Herrin J; Yale University School of Medicine, New Haven, CT., Soulos PR; Yale University School of Medicine, New Haven, CT., Potosky AL; Georgetown University School of Medicine, Washington, DC., Gross CP; Yale University School of Medicine, New Haven, CT. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Oct 20; Vol. 32 (30), pp. 3456-7. Date of Electronic Publication: 2014 Sep 02. |
DOI: | 10.1200/JCO.2014.57.6108 |
Databáze: | MEDLINE |
Externí odkaz: |